{"title":"Antidepressants given repeatedly increase the alpha 1-adrenoceptor agonist affinity in the rat brain.","authors":"V Klimek, J Zak-Knapik, J Maj","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Several different antidepressant drugs (AD): imipramine, amitriptyline, citalopram and mianserin were administered to rats at a dose of 10 mg/kg po, twice daily for 14 days. The competition studies showed that AD used enhanced the ability of alpha 1-agonist phenylephrine to inhibit the binding of [3H]-prazosin to its receptors (Ki values being decreased) in the cerebral cortex, thalamus and hippocampus. The present results show that the increase in the affinity of alpha 1-adrenoceptors for their agonist is responsible for the functional alpha 1-adrenergic hypersensitivity found after repeated treatment with different AD.</p>","PeriodicalId":20276,"journal":{"name":"Polish journal of pharmacology and pharmacy","volume":"43 5","pages":"347-52"},"PeriodicalIF":0.0000,"publicationDate":"1991-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polish journal of pharmacology and pharmacy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Several different antidepressant drugs (AD): imipramine, amitriptyline, citalopram and mianserin were administered to rats at a dose of 10 mg/kg po, twice daily for 14 days. The competition studies showed that AD used enhanced the ability of alpha 1-agonist phenylephrine to inhibit the binding of [3H]-prazosin to its receptors (Ki values being decreased) in the cerebral cortex, thalamus and hippocampus. The present results show that the increase in the affinity of alpha 1-adrenoceptors for their agonist is responsible for the functional alpha 1-adrenergic hypersensitivity found after repeated treatment with different AD.